Experimental Vaccine Shows Promising Results Against Aggressive Breast Cancer: Trial Results Reveal

The researchers believe the new vaccine has the potential to become a targeted treatment strategy to prevent tumor recurrence in triple-negative breast cancer. (Credit: Image by wayhomestudio on Freepik)

An experimental vaccine has shown promising results against an aggressive form of breast cancer, according to the results of a recent clinical trial.

The new neoantigen DNA vaccine developed for preventing the recurrence of tumors in triple-negative breast cancer was found to be "well-tolerated" and effective in stimulating the immune system, according to a small trial conducted at Washington University School of Medicine in St. Louis.